Literature DB >> 8299503

Clinical and metabolic factors associated with the blood retinal barrier permeability in insulin dependent diabetes mellitus without retinopathy.

J M Benitez del Castillo1, A Castillo, P C Fernandez, J Garcia Sanchez.   

Abstract

The authors assessed a study pointing out the relationship between the permeability of Blood Retinal Barrier (BRB), using vitreous fluorophotometry, and several risk clinical and laboratory data in Insulin Dependent Diabetes Mellitus (IDDM). Eighty eyes of 40 IDDM patients were evaluated. Their mean age was 14.8 +/- 3.2 years. Twenty healthy volunteers served as control group (mean age 15.3 +/- 3.2 years). Preexisting diabetic retinopathy was dismissed after funduscopy and fluorescein angiography. The studied risk factors were: age, duration of diabetes, HLA antigens, blood pressure, cholesterol and triglycerides levels, glycosylated hemoglobin, insulin dose/kg body weight and fructosamine. Vitreous and lens fluorophotometry was performed in both groups (VPRt). The mean VPRt in IDDM patients was 3.56 +/- 1.47 x 10(-6) min-1. In healthy subjects it was 2.53 +/- 0.55 x 10(-6) min-1, establishing a significant difference (p < 0.01). We found a statistically significant correlation between VPRt and duration of diabetes, insulin dose/kg body weight and HbAlc. No correlation was found between VPRt and the rest of parameters. We conclude that vitreous fluorophotometry is a valid method to measure BRB; and the three factors mentioned above are related to the BRB permeability.

Entities:  

Mesh:

Year:  1993        PMID: 8299503     DOI: 10.1007/BF01206247

Source DB:  PubMed          Journal:  Doc Ophthalmol        ISSN: 0012-4486            Impact factor:   2.379


  35 in total

1.  Does vitreous fluorophotometry reflect severity of early diabetic retinopathy?

Authors:  W E Plehwe; M A Sleightholm; E M Kohner
Journal:  Br J Ophthalmol       Date:  1989-04       Impact factor: 4.638

2.  In vivo assessment of lens transmission for blue-green light by autofluorescence measurement.

Authors:  J A van Best; E W Tsoi; J P Boot; J A Oosterhuis
Journal:  Ophthalmic Res       Date:  1985       Impact factor: 2.892

3.  Technical variables in vitreous fluorophotometry.

Authors:  B P Conway
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  1985       Impact factor: 3.117

4.  Effect of vitreous detachment on vitreous fluorophotometry.

Authors:  A Yoshida; H Furukawa; F C Delori; S E Bursell; C L Trempe; J W McMeel
Journal:  Arch Ophthalmol       Date:  1984-06

5.  Sequential vitreous fluorophotometry in diabetes mellitus: a five-year prospective study.

Authors:  S R Waltman
Journal:  Trans Am Ophthalmol Soc       Date:  1984

6.  Glycosylated hemoglobin predicts the incidence and progression of diabetic retinopathy.

Authors:  R Klein; B E Klein; S E Moss; M D Davis; D L DeMets
Journal:  JAMA       Date:  1988-11-18       Impact factor: 56.272

7.  Permeability of the blood-ocular barrier in adolescent and adult diabetic patients.

Authors:  A Yoshida; S Ishiko; M Kojima; H Ogasawara
Journal:  Br J Ophthalmol       Date:  1993-03       Impact factor: 4.638

8.  Blood pressure and retinopathy in type I diabetes.

Authors:  H P Chase; S K Garg; W E Jackson; M A Thomas; S Harris; G Marshall; M J Crews
Journal:  Ophthalmology       Date:  1990-02       Impact factor: 12.079

9.  Vitreous fluorophotometry in juvenile diabetics after oral fluorescein.

Authors:  G Nuzzi; M Vanelli; I Venturini; M Bonacini; E Boselli
Journal:  Arch Ophthalmol       Date:  1986-11

10.  Vitreous fluorophotometry in patients with no or minimal diabetic retinopathy.

Authors:  P Chahal; T J Fallon; S J Jennings; P J Chowienczyk; E M Kohner
Journal:  Diabetes Care       Date:  1986 Mar-Apr       Impact factor: 19.112

View more
  2 in total

1.  Permeability of the blood-retinal barrier in healthy humans. European Concerted Action on Ocular Fluorometry.

Authors:  H J Van Schaik; B Heintz; M Larsen; E Leite; V Rosas; R Schalnus; J A Van Best
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  1997-10       Impact factor: 3.117

2.  Analysis of the blood-retinal barrier: its relation to clinical and metabolic factors and progression to retinopathy in juvenile diabetics. A 4-year follow-up study.

Authors:  A Castillo; J M Benitez del Castillo; D Diaz; O Sayagues; J L Ruibal; J Garcia-Sanchez
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  1996-04       Impact factor: 3.117

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.